KR940003550A - 노인성 치매 예방 및 치료방법 - Google Patents

노인성 치매 예방 및 치료방법 Download PDF

Info

Publication number
KR940003550A
KR940003550A KR1019930015610A KR930015610A KR940003550A KR 940003550 A KR940003550 A KR 940003550A KR 1019930015610 A KR1019930015610 A KR 1019930015610A KR 930015610 A KR930015610 A KR 930015610A KR 940003550 A KR940003550 A KR 940003550A
Authority
KR
South Korea
Prior art keywords
senile dementia
prevent
calpine
dementia
treat senile
Prior art date
Application number
KR1019930015610A
Other languages
English (en)
Inventor
사이또오겐이찌
랄프앙구스닉슨
Original Assignee
마아빈 씨 구트리에, 제이. 디.
더 맥린 호스피탈 코오포레이숀
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마아빈 씨 구트리에, 제이. 디., 더 맥린 호스피탈 코오포레이숀 filed Critical 마아빈 씨 구트리에, 제이. 디.
Publication of KR940003550A publication Critical patent/KR940003550A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

칼파인 억제제를 필수 성분으로 함유하는 노인성 치매 치료제 또는 예방제를 제공한다.

Description

노인성 치매 예방 및 치료방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 노인성 치매 또는 헌팅톤 질환 환자와정상인 (대조)에 있어서 칼파인 I의 나타내는 그래프.

Claims (4)

  1. 필수성분으로서 칼파인 억제제를 함유하는 노인
  2. 필수 성분으로서 칼파인 억제제를 항유하고 이와 치매 치료 또는 예방을 위한 약제학적 조성물.
  3. 노인성 치때 환자 또는 노인성 치매의 우려가 있는 더불어 약제학적으로 허용되는 담체를 함유하는 노인성 치료방법.
  4. 노인성 치매의 치료 또는 예방을 위한 칼파인 억제제의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930015610A 1992-08-14 1993-08-12 노인성 치매 예방 및 치료방법 KR940003550A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93064792A 1992-08-14 1992-08-14
US7/930,647 1992-08-14

Publications (1)

Publication Number Publication Date
KR940003550A true KR940003550A (ko) 1994-03-12

Family

ID=25459574

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930015610A KR940003550A (ko) 1992-08-14 1993-08-12 노인성 치매 예방 및 치료방법

Country Status (4)

Country Link
JP (1) JPH06172211A (ko)
KR (1) KR940003550A (ko)
CA (1) CA2101417A1 (ko)
TW (1) TW268896B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69815137T2 (de) * 1997-09-04 2004-04-08 Nippon Chemiphar Co. Ltd. Epoxybernsteinsäureamid-derivate

Also Published As

Publication number Publication date
JPH06172211A (ja) 1994-06-21
CA2101417A1 (en) 1994-02-15
TW268896B (ko) 1996-01-21

Similar Documents

Publication Publication Date Title
EP1649853A3 (en) Microtubule stabilizing agents for treating atherosclerosis or restenosis
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
IE893840L (en) Use of acetyl d-carnitines for treating glaucoma
KR930702000A (ko) 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
ATE146677T1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
KR910004187A (ko) 세트랄린을 사용한 조기사정의 치료방법
PT914110E (pt) Metodo de modulacao da micro-circulacao
FI930038A0 (fi) Minskande eller foerhindrande av hudirritation med laekemedel
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
HUP0001063A2 (hu) Zöld porfirinek alkalmazása ateroszklerózis kezelésére szolgáló gyógyászati készítmények előállítására
KR970061244A (ko) 치매 치료용 약학 조성물
DE3778008D1 (de) Ketonderivate als arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
KR950016760A (ko) 치질 치료제
ES2196167T3 (es) Composicion farmaceutica que contiene propionato de 3-(2,2,2-trimetilhidrazinio) y gamma-butirobetaina para el tratamiento de enfermedades cardiovasculares.
ES2096207T3 (es) Prevencion y tratamiento de aterosclerosis.
KR960703593A (ko) (R)-암로디핀에 의한 평활근 세포 이동의 억제 (Inhibition of Smooth Muscle Cell Migration by (R)-Amlodipine)
KR940003550A (ko) 노인성 치매 예방 및 치료방법
ES2104223T3 (es) 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.
DE69424679T2 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
RU96115138A (ru) Применение диметикона для лечения запоров
KR960003741A (ko) 조골세포 증식인자
ATE316373T1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination